SYNOVA HEALTHCARE GROUP, INC.Securities Agreement • February 26th, 2007 • Synova Healthcare Group Inc • In vitro & in vivo diagnostic substances
Contract Type FiledFebruary 26th, 2007 Company IndustryTHIS NOTE is one of a series of duly authorized and issued notes of Synova Healthcare Group, Inc., a Nevada corporation (the “Company”), designated as its 6.5% Senior Convertible Promissory Notes due January 12, 2012, in the original aggregate principal amount of fifteen million dollars ($15,000,000) (collectively, the “Notes” and each Note comprising the Notes, a “Note”).
SYNOVA HEALTHCARE GROUP, INC.Securities Agreement • January 17th, 2007 • Synova Healthcare Group Inc • In vitro & in vivo diagnostic substances
Contract Type FiledJanuary 17th, 2007 Company IndustryTHIS NOTE is one of a series of duly authorized and issued notes of Synova Healthcare Group, Inc., a Nevada corporation (the “Company”), designated as its 6.5% Senior Convertible Promissory Notes due January 12, 2012, in the original aggregate principal amount of fifteen million dollars ($15,000,000) (collectively, the “Notes” and each Note comprising the Notes, a “Note”).